MyAverix Finance
HK · Healthcare
Ab&B Bio-Tech Co Ltd JS (2627)
Drug Manufacturers - Specialty & Generic
Ab&B Bio-Tech Co Ltd JS (2627) is listed on HK in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-21, reported market cap is $11.54B, P/E ratio is 18.00, net margin is -69.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 2627
Ab&B Bio-Tech Co Ltd JS (2627) — FAQ
What is Ab&B Bio-Tech Co Ltd JS's market cap?
Ab&B Bio-Tech Co Ltd JS (2627) has a reported market cap of $11.54B (data as of 2026-05-21).
What is 2627's P/E ratio?
The price-to-earnings (P/E) ratio for Ab&B Bio-Tech Co Ltd JS (2627) is 18.00 (data as of 2026-05-21).
Does Ab&B Bio-Tech Co Ltd JS pay a dividend?
Dividend yield is not available in the current snapshot for Ab&B Bio-Tech Co Ltd JS (2627). Check the MyAverix Finance app for the latest dividend data.
What sector is Ab&B Bio-Tech Co Ltd JS in?
Ab&B Bio-Tech Co Ltd JS (2627) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 2627 listed on?
2627 is listed on HK.
What is Ab&B Bio-Tech Co Ltd JS's net margin?
Ab&B Bio-Tech Co Ltd JS (2627) reports a net margin of -69.3% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.